BEIJING: China has approved 16 domestically made Covid-19 vaccines for clinical trials, six of which have entered phase 3, according to the latest data from the National Medical Products Administration.
Two inactivated Covid-19 vaccines from China have hit the market on a conditional basis: a vaccine from China National Biotec Group affiliated with Sinopharm, and the CoronaVac vaccine developed by Sinovac Biotech.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
